Results 21 to 30 of about 31,883 (222)
, 2023 IHC was negative for vascular endothelial marker CD105.
Joel E. Pessa (15412171)
core +1 more source
Placental markers of miscarriage
Patologìâ, 2021 Successful implantation involves a high degree of development of spiral arteries, combined with high proliferative activity, which ensures the formation of a healthy placenta, full uterine-placental circulation, and the birth of a healthy child.
A. A. Zhyvetska-Denysova +5 more
doaj +1 more source
Patologìâ, 2020 Aim – to study the features of VEGF, VEGFR-2 and CD31, CD105 immunohistochemical expression in the cerebral cortex in diabetes mellitus type 2. Materials and methods.
Avramenko Yu. M.
doaj +1 more source
CD105/endoglin expression in a mouse model of acute muscle contusion [PDF]
Romanian Journal of Neurology, 2014 Objectives. Muscle contusion is the most common form of muscle injury, and the muscle endogenous regenerative capacity can compensate for non-extensive damage. However, severe traumatic injuries may overcome this capacity.
Antoanela Curici +5 more
doaj +1 more source
Identification of CD105 (endoglin) as novel risk marker in CLL [PDF]
Annals of Hematology, 2022 AbstractSeveral genetic and clinical markers are established as prognostic factors in chronic lymphocytic leukemia (CLL). However, additional markers are needed for risk stratification. Flow cytometric analysis is a mainstay of CLL diagnostics, thus identification of novel prognostic surface markers can improve risk assessment without increasing burden
Sarah M. Greiner +11 more
openaire +2 more sources
Expression of endoglin (CD105) in cervical cancer [PDF]
British Journal of Cancer, 2009 In this study, we have investigated the role of endoglin (CD105), a regulator of transforming growth factor (TGF)-beta(1) signalling on endothelial cells, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor-A (VEGF-A) in cervical cancer.
Zijlmans, H. J. +6 more
openaire +3 more sources
PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
Heliyon, 2023 Purpos: CD105 has become a promising target of immunotherapy development for highly specific expression on the neovascular surface of most types of tumor cells.
Xi Wang +5 more
doaj +1 more source
Cancer Biology & Medicine, 2020 Objective: Bevacizumab is a recombinant humanized monoclonal antibody that blocks vascular endothelial growth factor (VEGF) with clear clinical benefits.
Xiaoling Zhang +9 more
doaj +1 more source
CD105 (Endoglin) as negative prognostic factor in AML [PDF]
Scientific Reports, 2019 AbstractWhile several genetic and morphological markers are established and serve to guide therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional markers to better stratify patients. CD105 (Endoglin) is a type I transmembrane protein reported to induce activation and proliferation of endothelial cells. In addition,
Joseph Kauer +8 more
openaire +2 more sources
Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma-0 [PDF]
, 2011 Copyright information:Taken from "Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma"http://www.biomedcentral.com/1471-2407/7/122BMC Cancer 2007;7():122-122.Published online 4 Jul ...
Yongzhong Yao (78060) +6 more
core +1 more source